US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has ...

Kim Assender, the Association of the British Pharmaceutical Industries’ (ABPI) director of commercial policy and analysis, ...

Italian biotech MimeTech has announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) ...

Swiss biopharma Relief Therapeutics today announced positive results from its pivotal bioequivalence clinical study ...

Shares in UK pharma major GSK were 6% higher late Wednesday after the London-based drugmaker presented its third quarter ...

Shares in Swiss pharma giant Novartis closed 4% lower Tuesday after the firm reported its third-quarter 2025 financial ...

South Korean biosimilar specialist Samsung Bioepis revealed it has entered into an asset purchase agreement (APA) with Biogen ...

US biotech Zag Bio announced the company’s launch with $80 million in financing, including a recently closed Series A financing.

US clinical stage biotech Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in ...

Sales of drugs against dementia are steadily growing in Russia these days, as the number of patients who suffer from the disease is also growing, The Pharma Letter’s local correspondent reports.

The European Medicines Agency (EMA) and its Committee for Medicinal Products for Human Use (CHMP) set the pace in Europe, ...

Australian biotech Myrio Therapeutics has joined forces with the University of Pennsylvania’s Perelman School of Medicine and ...